Drug Resistance in Tuberculosis: How to Counter The Menace?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|12|1158-1165

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.12, 2014-12, pp. : 1158-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Frontiers in the Therapy of Tuberculosis: Fighting with the Global Menace

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-04 ,pp. : 401-430

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Iron Chelation and Drug Resistance in Cancer and Tuberculosis)

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 12, 2014-12 ,pp. : 1093-1094

Bentham Science Publishers

Access to resources Recommend Favorite

Current Nanotechnological Approaches for an Effective Delivery of Bioactive Drug Molecules to Overcome Drug Resistance Tuberculosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3076-3089

Bentham Science Publishers

Access to resources Recommend Favorite

How can we identify parasite genes that underlie antimalarial drug resistance?

By Anderson Tim   Nkhoma Standwell   Ecker Andrea   Fidock David  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 59-85

Future Medicine

Access to resources Recommend Favorite

Tuberculosis Drug Targets

By  

Current Drug Targets, Vol. 3, Iss. 2, 2002-04 ,pp. : 131-154

Bentham Science Publishers

Access to resources Recommend Favorite